Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.

We correlated bone marrow cytogenetic findings with morphologic and immunophenotypic data in 37 patients with lymphoplasmacytic lymphoma (LPL)/Waldenström macroglobulinemia (WM). Each LPL/WM case was classified as lymphoplasmacytoid (n = 18), lymphoplasmacytic (n = 10), or polymorphous (n = 9) using the Kiel criteria. Of 12 cases with chromosomal abnormalities, a single numeric abnormality was present in 4 and a complex karyotype in 8. The most common numeric abnormalities were and -8 in 3 cases each; the most common structural abnormality was del(6q) in 6 cases. Cytogenetic abnormalities were significantly less common in the lymphoplasmacytic and lymphoplasmacytoid groups (5/28 [18%]) compared with the polymorphous group (7/9 [78%]). Clinical follow-up was available for 28 patients for a median of 36 months. Six (67%) of 9 patients with aneuploid tumors, including 4 with polymorphous subtype, subsequently had clinical progression or developed high-grade lymphoma. In contrast, 4 (21%) of 19 patients with diploid tumors, including 1 of polymorphous type, developed clinical progression or high-grade lymphoma. We conclude that abnormal cytogenetic findings in LPL/WM correlate with the polymorphous subtype and poor prognosis.

[1]  J. Dierlamm Genetic abnormalities in marginal zone B-cell lymphoma. , 2003, Haematologica.

[2]  L. Pease,et al.  Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor. , 2001, Blood.

[3]  B. Grosbois,et al.  patients with the description of a new scoring system and its validation on 253 other patients. , 2000, Blood.

[4]  G. Morgan,et al.  Waldenström's macroglobulinaemia: Laboratory diagnosis and treatment , 2000, Hematological oncology.

[5]  G. Morgan,et al.  Clinicopathological correlates of IgM paraproteinemias. , 2000, Clinical lymphoma.

[6]  G Flandrin,et al.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  R. Siebert,et al.  Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group. , 1999, Blood.

[9]  P. Wiernik,et al.  Multiple karyotypic aberrations in a polymorphous variant of Waldenström macroglobulinemia. , 1999, Cancer genetics and cytogenetics.

[10]  O. Haas,et al.  Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. , 1998, Blood.

[11]  A case of t(8;14) with total and partial trisomy 3 in Waldenstrom macroglobulinemia. , 1998, Cancer genetics and cytogenetics.

[12]  C. Preudhomme,et al.  THE CLINICAL SIGNIFICANCE OF MUTATIONS OF THE P52 TUMOUR SUPPRESSOR GENE IN HAEMATOLOGICAL MALIGNANCIES , 1997, British journal of haematology.

[13]  R. Siebert,et al.  Frequent deletions of 6q23–24 in B‐cell non‐Hodgkin's lymphomas detected by fluorescence in situ hybridization , 1997, Genes, chromosomes & cancer.

[14]  R. Dalla‐Favera,et al.  The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. , 1996, Blood.

[15]  B. Nathwani,et al.  Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[16]  H. Nawata,et al.  [Primary macroglobulinemia with t(11;18) (q21;q21)]. , 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[17]  L. Foroni,et al.  Deletion of chromosome 13 (band ql4) but not trisomy 12 is a clonal event in B‐chronic lymphocytic leukaemia (CLL) , 1995, British journal of haematology.

[18]  Y. Kwong,et al.  Concomitant partial tetrasomy 3q and trisomy 18 in Waldenström macroglobulinemia. , 1995, Cancer genetics and cytogenetics.

[19]  P. Isaacson,et al.  Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. , 1995, Blood.

[20]  N. Weiss,et al.  Incidence of Waldenström's macroglobulinemia. , 1993, Blood.

[21]  K Offit,et al.  t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. , 1992, Blood.

[22]  F. Caradonna,et al.  Chromosomal abnormalities in Waldenström's macroglobulinemia. , 1992, Cancer genetics and cytogenetics.

[23]  F. Mitelman ISCN 1991 : guidelines for cancer cytogenetics : supplement to An international system for human cytogenetic nomenclature : recommendations of the Standing Committee on Human Cytogenetic Nomenclature, Subcommittee on Cancer Cytogenetics , 1992 .

[24]  P. Wiernik,et al.  Neoplastic Diseases of the Blood , 1991 .

[25]  M. Ladanyi,et al.  Cytogenetic analysis of 434 consecutively ascertained specimens of non‐Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment , 1991, Genes, chromosomes & cancer.

[26]  L. Stuppia,et al.  Chromosome changes in 19 patients with Waldenström's macroglobulinemia. , 1987, Cancer genetics and cytogenetics.

[27]  R. Kyle,et al.  The spectrum of IgM monoclonal gammopathy in 430 cases. , 1987, Mayo Clinic proceedings.

[28]  C. S. San Román,et al.  Clonal abnormalities in patients with Waldenström's macroglobulinemia with special reference to a Burkitt-type t(8;14). , 1985, Cancer genetics and cytogenetics.

[29]  G. Hoffmann-Fezer,et al.  Bone marrow histology in Waldenström's macroglobulinaemia. Clinical relevance of subtype recognition. , 2009, Scandinavian journal of haematology.

[30]  K. Takatsuki,et al.  Cytogenetic studies and clinical aspects of patients with plasma cell leukemia and leukemic macroglobulinemia. , 1983, Cancer research.

[31]  E. Henderson,et al.  Clonal chromosome abnormalities in patients with Waldenström's and CLL-associated macroglobulinemia: significance of trisomy 12. , 1983, Blood.

[32]  O. Olivares,et al.  [Waldenström's macroglobulinemia]. , 1966, Revista medica de Chile.